Abstract

26P Subcutaneous trastuzumab versus intravenous trastuzumab for treatment of patients with HER2-positive breast cancer: A time, motion and cost-benefit assessment in a day care oncology unit in China

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Subcutaneous trastuzumab (Herceptin) versus intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: A time, motion and cost assessment study in a lean operating day care oncology unit
Wiebren A.A Tjalma ... Konstantinos Papadimitriou
European journal of obstetrics, gynecology, and reproductive biology | VOL. 221
Wiebren A.A Tjalma, et. al.Wiebren A.A Tjalma ... Konstantinos Papadimitriou
07 Dec 2017
Abstract P4-21-15: Trastuzumab IV versus SC: A time, motion and cost assessment in a lean operating day care oncology unit
Waa Tjalma ... K Papadimitriou
American Journal of Cancer | VOL. 77
Waa Tjalma, et. al.Waa Tjalma ... K Papadimitriou
14 Feb 2017
Abstract P4-09-03: The Clinical Characteristics of HER2 Positive Early Breast Cancer with Basal Marker Co-Expression
S Park ... Ey Cho
American Journal of Cancer | VOL. 70
S Park, et. al.S Park ... Ey Cho
15 Dec 2010
Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer.
Zhang Xiping ... Yang Hongjian
Oncotarget | VOL. 9
Zhang Xiping, et. al.Zhang Xiping ... Yang Hongjian
18 Dec 2017
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022
R.A Freedman ... N.U Lin
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R.A Freedman, et. al.R.A Freedman ... N.U Lin
06 Jul 2024
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma.
Sebastiano Biondo ... Esther Kreisler
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Sebastiano Biondo, et. al.Sebastiano Biondo ... Esther Kreisler
03 Jul 2024
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Elevating Cancer on the Global Health Agenda: Towards the 4th High-Level Meeting on NCDs 2025
Raffaella Casolino ... Andrè Ilbawi
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Raffaella Casolino, et. al.Raffaella Casolino ... Andrè Ilbawi
01 Jul 2024
View more papers